Dr. Gary Wang, MD

NPI: 1053382051
Total Payments
$1,459
2024 Payments
$346.82
Companies
22
Transactions
58
Medicare Patients
1,137
Medicare Billing
$128,462

Payment Breakdown by Category

Food & Beverage$1,459 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,459 58 100.0%

Top Paying Companies

Company Total Records Latest Year
Indivior Inc. $330.05 13 $0 (2024)
US WorldMeds, LLC $314.16 11 $0 (2019)
Collegium Pharmaceutical, Inc. $133.20 4 $0 (2018)
Daiichi Sankyo Inc. $100.00 1 $0 (2017)
JAZZ PHARMACEUTICALS INC. $67.92 2 $0 (2024)
Supernus Pharmaceuticals, Inc. $51.58 3 $0 (2018)
SHIELD THERAPEUTICS INC $50.74 3 $0 (2024)
Sunovion Pharmaceuticals Inc. $48.98 3 $0 (2018)
Alkermes, Inc. $42.05 2 $0 (2018)
ITF Therapeutics LLC $40.77 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $346.82 15 JAZZ PHARMACEUTICALS INC. ($67.92)
2023 $38.90 2 Shield Therapeutics Inc ($20.01)
2022 $28.70 2 Fidia Pharma USA Inc. ($15.25)
2020 $34.00 2 Ipsen Biopharmaceuticals, Inc ($17.88)
2019 $465.90 14 US WorldMeds, LLC ($236.32)
2018 $382.65 19 Collegium Pharmaceutical, Inc. ($133.20)
2017 $161.83 4 Daiichi Sankyo Inc. ($100.00)

All Payment Transactions

58 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
12/18/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $20.01 General
Category: Diabetes
12/13/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $14.18 General
Category: Immunology
12/03/2024 IRONSHORE PHARMACEUTICALS INC. JORNAY PM (Drug) Food and Beverage Cash or cash equivalent $24.07 General
Category: CENTRAL NERVOUS SYSTEM STIMULANT
11/29/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $19.03 General
Category: Immunology
11/22/2024 Insulet Corporation Omnipod (Device) Food and Beverage Cash or cash equivalent $16.00 General
Category: Insulin Pump
10/02/2024 ITF Therapeutics LLC Food and Beverage In-kind items and services $40.77 General
09/27/2024 SHIELD THERAPEUTICS INC ACCRUFER (Drug) Food and Beverage In-kind items and services $16.38 General
Category: Hematology
09/26/2024 IBSA Pharma Inc. Tirosint (Drug), Licart, Flector Food and Beverage Cash or cash equivalent $19.96 General
Category: Endocrinology
08/06/2024 JAZZ PHARMACEUTICALS INC. EPIDIOLEX (Drug) Food and Beverage In-kind items and services $33.96 General
Category: NEUROLOGY
08/06/2024 JAZZ PHARMACEUTICALS INC. EPIDIOLEX (Drug) Food and Beverage In-kind items and services $33.96 General
Category: NEUROLOGY
08/02/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $27.19 General
Category: GASTROENTEROLOGY
07/02/2024 Inspire Medical Systems, Inc. INSPIRE (Device) Food and Beverage In-kind items and services $25.74 General
Category: NEUROLOGY
06/25/2024 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $14.96 General
Category: Diabetes
06/14/2024 Indivior Inc. SUBLOCADE (Drug) Food and Beverage In-kind items and services $26.26 General
Category: OUD
03/01/2024 SHIELD THERAPEUTICS INC ACCRUFER (Drug) Food and Beverage In-kind items and services $14.35 General
Category: Hematology
10/27/2023 Shield Therapeutics Inc ACCRUFER (Drug) Food and Beverage In-kind items and services $20.01 General
Category: Hematology
04/27/2023 Indivior Inc. SUBLOCADE (Drug) Food and Beverage In-kind items and services $18.89 General
Category: OUD
11/21/2022 Indivior Inc. SUBLOCADE (Drug) Food and Beverage In-kind items and services $13.45 General
Category: OUD
09/19/2022 Fidia Pharma USA Inc. HYMOVIS (Device), TRILURON Food and Beverage In-kind items and services $15.25 General
Category: OSTEOARTHRITIS
09/29/2020 Ipsen Biopharmaceuticals, Inc DYSPORT (Drug) Food and Beverage In-kind items and services $17.88 General
Category: Neurology
01/30/2020 Indivior Inc. SUBLOCADE (Drug) Food and Beverage In-kind items and services $16.12 General
Category: OUD
12/05/2019 Indivior Inc. SUBLOCADE (Drug) Food and Beverage In-kind items and services $20.00 General
Category: OUD
10/10/2019 Indivior Inc. SUBLOCADE (Drug) Food and Beverage In-kind items and services $16.82 General
Category: OUD
09/14/2019 US WorldMeds, LLC Lucemyra/Lofexidine (Drug) Food and Beverage In-kind items and services $12.63 General
Category: Psychiatry/Psychology
08/23/2019 Indivior Inc. SUBLOCADE (Drug) Food and Beverage In-kind items and services $16.90 General
Category: OUD

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 168 336 $40,122 $20,311
2022 13 407 858 $91,815 $48,268
2021 11 273 663 $62,361 $32,691
2020 10 289 661 $63,491 $27,192
Total Patients
1,137
Total Services
2,518
Medicare Billing
$128,462
Procedure Codes
41

All Medicare Procedures & Services

41 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 40 103 $17,270 $9,238 53.5%
80307 Testing for presence of drug, by chemistry analyzers Office 2023 35 75 $8,080 $4,515 55.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 27 54 $7,040 $3,138 44.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 15 15 $3,522 $1,585 45.0%
98926 Osteopathic manipulative treatment, 3-4 body regions Office 2023 23 31 $2,325 $995.52 42.8%
Q3014 Telehealth originating site facility fee Office 2023 14 29 $1,160 $569.12 49.1%
G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic Office 2023 14 29 $725.00 $270.75 37.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 60 154 $23,483 $14,109 60.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 54 139 $16,172 $8,214 50.8%
80307 Testing for presence of drug, by chemistry analyzers Office 2022 47 131 $14,410 $7,972 55.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 19 24 $4,730 $3,065 64.8%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 16 19 $4,940 $2,900 58.7%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 19 19 $5,636 $2,748 48.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 22 22 $5,329 $2,449 46.0%
Q3014 Telehealth originating site facility fee Office 2022 38 97 $3,880 $1,880 48.5%
98926 Osteopathic manipulative treatment, 3-4 body regions Office 2022 33 55 $4,125 $1,822 44.2%
80305 Testing for presence of drug, read by direct observation Office 2022 33 71 $4,055 $886.92 21.9%
G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic Office 2022 37 93 $2,325 $875.35 37.6%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2022 12 13 $1,170 $858.51 73.4%
97110 Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes Office 2022 17 21 $1,560 $486.02 31.2%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 44 111 $17,084 $10,237 59.9%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 34 125 $14,928 $7,443 49.9%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 21 21 $5,684 $3,532 62.1%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2021 13 33 $4,730 $2,743 58.0%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 12 14 $2,630 $1,956 74.4%

About Dr. Gary Wang, MD

Dr. Gary Wang, MD is a Physical Medicine & Rehabilitation healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053382051.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Wang, MD has received a total of $1,459 in payments from pharmaceutical and medical device companies, with $346.82 received in 2024. These payments were reported across 58 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,459).

As a Medicare-enrolled provider, Wang has provided services to 1,137 Medicare beneficiaries, totaling 2,518 services with total Medicare billing of $128,462. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.

Practice Information

  • Specialty Physical Medicine & Rehabilitation
  • Location Buffalo, NY
  • Active Since 01/28/2006
  • Last Updated 01/13/2023
  • Taxonomy Code 208100000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1053382051

Products in Payments

  • SUBLOCADE (Drug) $330.05
  • Lucemyra/Lofexidine (Drug) $314.16
  • Morphabond ER (Drug) $100.00
  • NucyntaER (Drug) $93.34
  • EPIDIOLEX (Drug) $67.92
  • OXTELLAR XR (Drug) $51.58
  • ACCRUFER (Drug) $50.74
  • Vivitrol 380 mg (Drug) $42.05
  • Fabhalta (Drug) $33.21
  • APTIOM (Drug) $30.64
  • XTAMPZA (Drug) $29.66
  • Levorphanol (Drug) $29.56
  • VOQUEZNA (Drug) $27.19
  • INSPIRE (Device) $25.74
  • GELSYN 3 (Device) $24.61
  • JORNAY PM (Drug) $24.07
  • MOUNJARO (Drug) $20.01
  • Tirosint (Drug) $19.96
  • BROVANA (Drug) $18.34
  • DYSPORT (Drug) $17.88

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physical Medicine & Rehabilitation Doctors in Buffalo